Oral vaccine developer PaxVax Corp. has hired a trio of officers as it prepares to take its lead cholera vaccine into Phase III trials.
The company, based in Menlo Park, hired Nima Farzan as executive vice president and chief operating officer, Dr. Thomas Monath as chief technology officer and Jonathan Smith as executive vice president and chief scientific officer.
No comments:
Post a Comment